ZNF721 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.997800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.223400E-01
Normal-vs-Stage2
4.930600E-01
Normal-vs-Stage3
3.419800E-01
Normal-vs-Stage4
4.920600E-01
Stage1-vs-Stage2
7.622400E-02
Stage1-vs-Stage3
1.524060E-03
Stage1-vs-Stage4
1.590790E-01
Stage2-vs-Stage3
1.175490E-03
Stage2-vs-Stage4
7.824000E-01
Stage3-vs-Stage4
2.491400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.273600E-01
Normal-vs-AfricanAmerican
4.447000E-01
Normal-vs-Asian
8.198600E-01
Caucasian-vs-AfricanAmerican
8.292800E-01
Caucasian-vs-Asian
3.684600E-01
AfricanAmerican-vs-Asian
3.501200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.275200E-01
Normal-vs-Female
6.596200E-01
Male-vs-Female
5.084000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.978600E-01
Normal-vs-Age(41-60Yrs)
7.366600E-01
Normal-vs-Age(61-80Yrs)
5.525000E-01
Normal-vs-Age(81-100Yrs)
4.861800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.862400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.505400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.208300E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.854800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.364500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.477950E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.145600E-01
Normal-vs-Daily Drinker
6.228000E-01
Normal-vs-Weekly Drinker
2.241600E-01
Normal-vs-Occasional Drinker
7.115400E-01
Normal-vs-Social Drinker
5.325600E-01
Non Drinker-vs-Daily Drinker
9.448200E-01
Non Drinker-vs-Weekly Drinker
2.641000E-01
Non Drinker-vs-Occasional Drinker
4.165400E-01
Non Drinker-vs-Social Drinker
6.803200E-01
Daily Drinker-vs-Weekly Drinker
2.786400E-01
Daily Drinker-vs-Occasional Drinker
4.800400E-01
Daily Drinker-vs-Social Drinker
6.959000E-01
Weekly Drinker-vs-Occasional Drinker
1.223840E-01
Weekly Drinker-vs-Social Drinker
2.813800E-01
Occasional Drinker-vs-Social Drinker
8.984200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.164210E-01
Normal-vs-Grade 2
1.241570E-01
Normal-vs-Grade 3
4.418400E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.211000E-01
Grade 1-vs-Grade 3
6.009800E-01
Grade 1-vs-Grade 4
1.164210E-01
Grade 2-vs-Grade 3
6.645400E-01
Grade 2-vs-Grade 4
1.241570E-01
Grade 3-vs-Grade 4
4.418400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.978800E-01
Normal-vs-NonDiabetic
5.926400E-01
Diabetic-vs-NonDiabetic
4.149600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.535600E-01
Normal-vs-NoPancreatitis
5.600400E-01
Pancreatitis-vs-NoPancreatitis
3.167800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.952000E-01
Normal-vs-N1
5.064800E-01
N0-vs-N1
7.790200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.940000E-01
Normal-vs-TP53-NonMutant
7.581800E-01
TP53-Mutant-vs-TP53-NonMutant
8.126800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
